Earlier today, tech giant IBM (IBM) announced that 11 of its AI and automation tools, including several from its watsonx lineup, are now approved for use by U.S. government agencies. This approval, known as FedRAMP, means that the software meets strict security and compliance standards. The approval was made possible through a partnership with Amazon Web Services (AMZN), as all of these tools run on AWS GovCloud, a secure cloud built specifically for government use.
Claim 30% Off TipRanks
Forget margin or options. Here's how the pros trade IBMAs a result, agencies can use these AI tools without having to manage the systems themselves, thereby making it easier to adopt new technology while staying secure. Unsurprisingly, this is a big step forward for IBM in the government market. In fact, the company said that its number of FedRAMP-approved products has increased fourfold in just one year, which suggests it is making a strong push into this space. IBM explained that government agencies need AI tools that are both powerful and safe to use, especially for sensitive work.
Meanwhile, AWS said that the partnership helps agencies modernize faster while still meeting strict security and reliability requirements, which are critical for government operations. Interestingly, these 11 tools cover a wide range of uses. For instance, some help build and run AI models (like watsonx.ai), while others focus on managing data, making sure AI is used responsibly, and automating tasks to improve efficiency. In addition, there are tools for security, like managing who can access systems, as well as tools that monitor performance and help maintain important infrastructure.
Is IBM a Buy, Sell, or Hold?
Turning to Wall Street, analysts have a Moderate Buy consensus rating on IBM stock based on 11 Buys, six Holds, and zero Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average IBM price target of $332.94 per share implies 37% upside potential.
